| 書目名稱 | Colorectal Cancer | | 副標(biāo)題 | Evidence-based Chemo | | 編輯 | Maurie Markman,Leonard B. Saltz | | 視頻video | http://file.papertrans.cn/230/229763/229763.mp4 | | 概述 | Includes supplementary material: | | 叢書名稱 | Current Clinical Oncology | | 圖書封面 |  | | 描述 | Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made. | | 出版日期 | Book 2007 | | 關(guān)鍵詞 | angiogenesis; cancer; cancer treatment; colon; colorectal cancer; imaging; liver; metastasis; metastatic dis | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-59745-215-1 | | isbn_softcover | 978-1-61737-756-3 | | isbn_ebook | 978-1-59745-215-1Series ISSN 2364-1134 Series E-ISSN 2364-1142 | | issn_series | 2364-1134 | | copyright | Humana Press 2007 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-6 12:48
發(fā)表于 2025-3-21 16:17:04
